BofA raised the firm’s price target on Omega Healthcare (OHI) to $43 from $39 and keeps a Neutral rating on the shares. For the second consecutive quarter, the company has exceeded the firm’s expectations, the analyst tells investors. Tenant issues appear to be largely behind, and it is off to a better-than-expected start in Q4, the firm adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $43 from $39 at RBC Capital
- Omega Healthcare Investors Shows Strong Q3 Performance
- Omega Healthcare upgraded to Outperform from Neutral at Exane BNP Paribas
- Omega Healthcare raises FY24 AFFO view to $2.84-$2.86, consensus $2.83
- Omega Healthcare reports Q3 AFFO 74c, consensus 71c